Artiva Biotherapeutics, Inc. (ARTV) — SC 13D Filings
All SC 13D filings from Artiva Biotherapeutics, Inc.. Browse 2 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (2)
-
GC Corp. Boosts Artiva Biotherapeutics Stake to 21.9%
— Jul 29, 2024 Risk: medium
On July 29, 2024, GC Corp. filed a Schedule 13D, reporting beneficial ownership of Artiva Biotherapeutics, Inc. common stock. GC Corp. previously held 10,670,00 -
RA Capital Discloses Stake in Artiva Biotherapeutics
— Jul 29, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have filed a Schedule 13D on July 29, 2024, reg
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX